In addition, the composition of the Management Board of Dermapharm Holding SE will change: Dr. J?rgen Ott will leave the company by mutual agreement on 31 August 2022. As of 1 September 2022, Dr. Andreas Eberhorn (47) will take office as Chief Marketing Officer at Dermapharm. Dr. Andreas Eberhorn has many years of experience in the areas of marketing and sales and will be responsible for marketing and sales in his role on the Management Board of Dermapharm.

From 2014 to 2018, he was already responsible for the speciality business as a member of the Management Board of Hexal AG. Since 2018, he has been Country Head at Sandoz Austria and most recently Head of Retail Cluster II (Rx and OTC) for the European region at Sandoz.